Symptomatic Management of Acute Bronchitis in a 17-Year-Old
For this 17-year-old with mild fever and cough from presumed acute bronchitis, provide patient education about the expected 2-3 week duration of symptoms and offer only supportive care—no antibiotics, no routine antitussives, no bronchodilators, and no anti-inflammatory medications are recommended. 1, 2, 3
Core Management Principles
The most important intervention is setting appropriate expectations: the cough will likely persist for 2-3 weeks regardless of treatment 3, 4. This education alone improves patient satisfaction more than prescribing medications 5, 6.
What NOT to Do
Based on the 2020 CHEST expert panel guidelines, avoid routine prescription of 1:
- Antibiotic therapy (reduces cough by only ~0.5 days while exposing patients to adverse effects including allergic reactions, nausea, and C. difficile infection) 2, 4
- Antitussives (dextromethorphan, codeine)
- Inhaled beta-agonists (no benefit without underlying asthma/COPD) 2
- Inhaled anticholinergics
- Inhaled or oral corticosteroids
- Oral NSAIDs
- Antiviral therapy
The 2016 ACP/CDC guidelines explicitly state: "Clinicians should not perform testing or initiate antibiotic therapy in patients with bronchitis unless pneumonia is suspected" 2.
What TO Do
Symptomatic relief options (though evidence for effectiveness is limited) 2:
- Over-the-counter cough suppressants (dextromethorphan)
- Expectorants (guaifenesin)
- First-generation antihistamines (diphenhydramine)
- Decongestants (phenylephrine)
Important caveat: These medications have not been shown to shorten illness duration and carry minor adverse effects (nausea, vomiting, headache, drowsiness) 2. The FDA recommends against cough/cold preparations in children under 6 years 7, though at age 17, these are options if the patient desires symptom relief.
When to Reassess
Advise the patient to return if symptoms worsen or persist beyond expected timeframe 1. At that point, consider:
- Chest x-ray to rule out pneumonia
- Peak expiratory flow rate measurements
- Sputum culture
- Complete blood count and inflammatory markers (CRP)
This is critical because 65% of patients with recurrent "acute bronchitis" episodes actually have mild asthma 1. If symptoms worsen, differential diagnoses include asthma exacerbation, pertussis (if cough becomes paroxysmal with whooping or post-tussive emesis), or bacterial superinfection 4.
Key Clinical Pitfalls
Do not be misled by purulent (green/yellow) sputum—this reflects inflammatory cells and sloughed epithelial cells, not bacterial infection 2, 7. More than 90% of acute bronchitis cases are viral 2, 7.
Rule out pneumonia first: In immunocompetent patients under 70 years, pneumonia is unlikely if ALL of the following are absent 2:
- Tachycardia (HR >100 bpm)
- Tachypnea (RR >24 breaths/min)
- Fever (oral temp >38°C)
- Abnormal chest exam findings (rales, egophony, tactile fremitus)
If any of these are present, obtain chest imaging.
Communication Strategy
Call it a "chest cold" rather than "bronchitis"—this terminology reduces patient expectations for antibiotics while maintaining satisfaction 4, 7. Emphasize that antibiotics provide minimal benefit (half-day reduction in cough) while causing harm through adverse effects and antibiotic resistance 4, 8.